NCT03120364View on ClinicalTrials.gov

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

PHASE3CompletedINTERVENTIONAL
Enrollment

824

Participants

Timeline

Start Date

September 9, 2015

Primary Completion Date

December 16, 2015

Study Completion Date

April 28, 2016

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

NBP608

Preparation of Oka/SK strain of live, attenuated zoster virus

BIOLOGICAL

Zostavax

Preparation of Oka/Merck strain of live, attenuated zoster virus

Trial Locations (1)

152-703

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT03120364 - Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over | Biotech Hunter | Biotech Hunter